JL Li
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Transplantation top 10%
Papers in
-
- Ubiquitin and proteasome pathways 2
-
- Cancer, Hypoxia, and Metabolism 3
- Cancer-related molecular mechanisms research 2
- Co-authors
- Adrian L. Harris (6 shared papers)Zhenlin Li (2 shared papers)Graham Steers (2 shared papers)Syed Haider (2 shared papers)Min Liang (1 shared paper)Xu Yan (1 shared paper)Helen Turley (2 shared papers)Fang Hu (1 shared paper)
- Journals
- Oncogene (4 papers)British Journal of Cancer (2 papers)Journal of Radioanalytical and Nuclear Chemistry (1 paper)Clinical & Experimental Immunology (1 paper)Gene Therapy (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
JL Li
34 papers receiving 808 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 229
- Transplantation 36
- Molecular Biology 428
- Geophysics 77
- Oncology 120
Countries citing papers authored by JL Li
This map shows the geographic impact of JL Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JL Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JL Li more than expected).
Fields of papers citing papers by JL Li
This network shows the impact of papers produced by JL Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JL Li. The network helps show where JL Li may publish in the future.
Co-authors
The 25 scholars most cited alongside JL Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 117 | |
| 2 | 2009 | 92 | |
| 3 | 2008 | 91 | |
| 4 | Unique Carboniferous-Permian tectonic-metallogenic framework of Northern Xinjiang (NW China): Constraints for the tectonics of the southern Paleoasian Domain | 2006 | 68 |
| 5 | 2018 | 67 | |
| 6 | 2015 | 52 | |
| 7 | LncRNA CCAT1 as the unfavorable prognostic biomarker for cholangiocarcinoma. | 2017 | 48 |
| 8 | 2010 | 47 | |
| 9 | 2014 | 40 | |
| 10 | 2011 | 32 | |
| 11 | 2018 | 30 | |
| 12 | 2020 | 15 | |
| 13 | 2019 | 15 | |
| 14 | 2020 | 13 | |
| 15 | 2011 | 12 | |
| 16 | 2019 | 9 | |
| 17 | Geochemical characteristics and ~(40)Ar-~(39)Ar ages of the amphibolites and gabbros in Tarlang area:implications for tectonic evolution of the Chinese Altai. | 2007 | 8 |
| 18 | 2012 | 8 | |
| 19 | 2018 | 7 | |
| 20 | 2019 | 6 |
About JL Li
JL Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Physiology and Artificial Intelligence, having authored 36 papers that have together received 812 indexed citations. Recurring topics across this work include Geochemistry and Geologic Mapping (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Ubiquitin and proteasome pathways (2 papers), Geochemistry and Geochronology of Asian Mineral Deposits (2 papers), Cancer-related molecular mechanisms research (2 papers), Geological and Geochemical Analysis (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Cancer Research (229 citations), Transplantation (36 citations), Molecular Biology (428 citations), Geophysics (77 citations) and Oncology (120 citations). JL Li has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Adrian L. Harris, Zhenlin Li, Graham Steers, Syed Haider, Min Liang, Xu Yan, Helen Turley, Fang Hu, HL Liu and Matteo Morotti. Their work appears in journals such as Oncogene, British Journal of Cancer, Journal of Radioanalytical and Nuclear Chemistry, Clinical & Experimental Immunology and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.